» Articles » PMID: 34948322

Regulation of P53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family Members

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Dec 24
PMID 34948322
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Heat shock proteins (HSPs) are molecular chaperones that assist diverse cellular activities including protein folding, intracellular transportation, assembly or disassembly of protein complexes, and stabilization or degradation of misfolded or aggregated proteins. HSP40, also known as J-domain proteins (JDPs), is the largest family with over fifty members and contains highly conserved J domains responsible for binding to HSP70 and stimulation of the ATPase activity as a co-chaperone. Tumor suppressor p53 (p53), the most frequently mutated gene in human cancers, is one of the proteins that functionally interact with HSP40/JDPs. The majority of p53 mutations are missense mutations, resulting in acquirement of unexpected oncogenic activities, referred to as gain of function (GOF), in addition to loss of the tumor suppressive function. Moreover, stability and levels of wild-type p53 (wtp53) and mutant p53 (mutp53) are crucial for their tumor suppressive and oncogenic activities, respectively. However, the regulatory mechanisms of wtp53 and mutp53 are not fully understood. Accumulating reports demonstrate regulation of wtp53 and mutp53 levels and/or activities by HSP40/JDPs. Here, we summarize updated knowledge related to the link of HSP40/JDPs with p53 and cancer signaling to improve our understanding of the regulation of tumor suppressive wtp53 and oncogenic mutp53 GOF activities.

Citing Articles

Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions.

Cordani M, Garufi A, Benedetti R, Tafani M, Aventaggiato M, DOrazi G Biomolecules. 2024; 14(6).

PMID: 38927053 PMC: 11201733. DOI: 10.3390/biom14060649.


Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia.

Novikova S, Tolstova T, Kurbatov L, Farafonova T, Tikhonova O, Soloveva N Int J Mol Sci. 2024; 25(9).

PMID: 38731835 PMC: 11083274. DOI: 10.3390/ijms25094618.


Prognosis value of heat-shock proteins in esophageal and esophagogastric cancer: A systematic review and meta-analysis.

Nakamura E, Park A, Pereira M, Kikawa D, Tustumi F World J Gastrointest Oncol. 2024; 16(4):1578-1595.

PMID: 38660660 PMC: 11037039. DOI: 10.4251/wjgo.v16.i4.1578.


Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.

Isermann T, Schneider K, Wegwitz F, De Oliveira T, Conradi L, Volk V bioRxiv. 2024; .

PMID: 38464125 PMC: 10925225. DOI: 10.1101/2024.02.22.581507.


DNAJ heat shock protein family member C1 can regulate proliferation and migration in hepatocellular carcinoma.

Fan Y, Meng Z, Zhang C, Wei D, Wei W, Xie X PeerJ. 2023; 11:e15700.

PMID: 37520264 PMC: 10386825. DOI: 10.7717/peerj.15700.


References
1.
Wang T, Lin Y, Yang S, Chang P, Wang T, Chen C . Tid1-S regulates the mitochondrial localization of EGFR in non-small cell lung carcinoma. Oncogenesis. 2017; 6(7):e361. PMC: 5541714. DOI: 10.1038/oncsis.2017.62. View

2.
Walerych D, Olszewski M, Gutkowska M, Helwak A, Zylicz M, Zylicz A . Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions. Oncogene. 2009; 28(48):4284-94. DOI: 10.1038/onc.2009.281. View

3.
Masunaga S, Ono K, Takahashi A, Ohnishi T, Kinashi Y, Takagaki M . Radiobiological characteristics of solid tumours depending on the p53 status of the tumour cells, with emphasis on the response of intratumour quiescent cells. Eur J Cancer. 2002; 38(5):718-27. DOI: 10.1016/s0959-8049(01)00430-0. View

4.
Liu X, Li K, Wang L, Zhang M, Wang X . Variations of human heat shock proteins in multiple cancers. Clin Transl Med. 2021; 11(2):e320. PMC: 7888541. DOI: 10.1002/ctm2.320. View

5.
Sato T, Hayashi Y, Oya Y, Kondo T, Sugie K, Kaneda D . DNAJB6 myopathy in an Asian cohort and cytoplasmic/nuclear inclusions. Neuromuscul Disord. 2013; 23(3):269-76. DOI: 10.1016/j.nmd.2012.12.010. View